MESOTHELIOMA

This study tested a combination of two immunotherapy drugs, durvalumab and tremelimumab, in people with malignant pleural mesothelioma, a rare cancer of the lung lining. The trial included 19 participants whose cancer had worsened after standard chemotherapy. The goal was to see …

This study tested an experimental drug called INCB099318 in 105 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are limited…

This study tested a new drug called TAK-500, alone or with pembrolizumab, in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The goal was to check safety and see if the drug could shrink tumors. The trial was terminated early, so results are limited.

This early-phase study tested a new drug called SO-C101, alone or with pembrolizumab, in 115 people with advanced solid tumors (like lung, kidney, or skin cancer) that stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study …

This study aimed to collect tumor tissue from patients with lung, chest, ovarian, or bladder cancers, or those who had adoptive cell therapy, within three hours after death. Researchers wanted to study how tumors change and spread by comparing samples from different parts of the …